GBB is one of the nation’s leading complex litigation firms with particular expertise in representing whistleblowers. On behalf of its whistleblower clients, firm attorneys have recovered close to $5.5 billion for state and federal governments under False Claims Act. Most recently, the firm served as lead counsel in U.S. ex rel. Brown v. Celgene, which resulted in the recovery of $280 million for the federal government and state governments in July 2017.
Miller served in the North Carolina House of Representatives from 1993-1994, the North Carolina Senate from 1997 to 2002, and the United States House of Representatives from 2003 through 2013. An expert in the area of banking and financial services, Miller was a member of the House Financial Services Committee where he was one of the architects of the 2008 financial reform legislation, the Dodd-Frank Act, especially the creation of the Consumer Financial Protection Bureau and other consumer protections.
Miller earned his undergraduate degree from the University of North Carolina at Chapel Hill; he received a Master’s Degree from the London School of Economics and law degree from Columbia Law School. After graduation he served as a Clerk to Judge J. Dickson Phillips of the United States Court of Appeal for the Fourth Circuit. Before entering politics Miller was a trial lawyer in Raleigh, North Carolina.
“Brad Miller brings with him a deep knowledge of securities and finance laws along with laws governing pension funds and the protection of retiree benefits. His expertise is a perfect fit for GBB and the firm’s expansion plans,” said GBB Founding Partner, Justin Brooks.
“Our goal has been to build a firm with attorneys who are prominent in their areas and want to use their talents to advance the rule of law for the public interest,” said Founding Partner Reuben Guttman.
“There has been far too much misconduct in the financial sector,” Miller said, “and far too little accountability. The firm wants to take that misconduct on, and so do I.”
“The firm did good and important work to hold the mortgage industry accountable for foreclosure fraud,” Miller said. “There is much more to be done.”
GBB current attorneys include a former Commissioner of the OSHA Review Commission, a law professor who is a national expert on complex litigation and trial practice, a former attorney with the FDA and the EPA who also holds a medical license and continues to practice, and former federal law clerks and prosecutors.
About Guttman, Buschner & Brooks PLLC
Guttman Buschner & Brooks PLLC (GBB) is an elite litigation boutique with offices in Washington, D.C., Philadelphia, PA, and Wilmington, DE. More information on GBB can be found at www.GBBlegal.com. In addition to the recent Celgene litigation, attorneys at the firm represented the lead whistleblower in U.S. ex rel. McCoyd v, Abbott Labs, which involved the recovery of $1.6 billion for the government; one of six whistleblowers in U.S. ex rel. Graydon v. GSK which resulted in the recovery of $1.04 billion, one of the whistleblowers in U.S. ex rel. Demott v Pfizer which resulted in the recovery of $2.3 billion; the lead whistleblowers in U.S. ex rel. Sandler and Paris v. Pfizer, which resulted in recovery of $257.4 million; the lead whistleblower in U.S. ex rel. Szymoniak v. Bank of America, which resulted in the recovery of $95 million; three of the whistleblowers in U.S. ex rel. Doghramji v CHS, which resulted in the recovery of $97 million; the lead whistleblower in U.S, ex rel. Kurnik v. Amgen, which resulted in the aggregate recovery of $30 million from Amgen, Inc., Omnicare, and PharMerica Corp.; and U.S. ex rel. Abrahamsen v. Hudson Valley, which resulted in a recovery of $5.5 million to the federal government and state government.
SOURCE Guttman, Buschner & Brooks PLLC
Powered by WPeMatico